DBP B — Double Bond Pharmaceutical International AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK26.57m
- SEK25.51m
- SEK0.08m
Brief: Double Bond Pharmaceutical Q3 Operating Loss Narrows To SEK 2.1 Mln
Brief: Double Bond Pharmaceutical Says Received Eurasian Patent For Belogal Platform
Brief: Double Bond Pharma Signed A Distribution Agreement With Zoono
Brief: DBP Unit Signs Cooperation Agreement With GE Healthcare
Brief: Double Bond Pharmaceutical Raises About SEK 7.37 Mln Through Rights Issue
Brief: DBP: FarmPharma Receives EU Funding
Brief: Double Bond Pharmaceutical Receives EU Funding For SME Instrument Phase I
Brief: Double Bond Pharmaceutical International Carries Out Rights Issue Of About SEK 10.5 Million
Brief: Double Bond Pharma Signs Distribution Agreement With Euroresearch Srl
Brief: Double Bond Pharmaceutical International DBP Partners With Webpharma Spt In Norway
Brief: Double Bond Pharmaceutical International Gets SEK 1.3 Million In Directed Issue
Brief: Double Bond Pharmaceutical International Gets SEK 3 Mln In Directed Issue
Brief: Double Bond Pharmaceutical International Gets First Order From Closter Pharma
Brief: Double Bond Pharmaceutical: Si-Studio divests 400,000 B-shares
Brief: Double Bond Pharmaceutical About To Sell Temodex In Latin America
Brief: Double Bond Pharmaceutical International: Eurostar Project Belopenem To Start Oct 1, 2018
Brief: Double Bond Pharmaceutical Signs Partnership with ITMO University
Brief: DBP Signs Distribution Agreement With Apotek365
Brief: Double Bond Pharmaceutical Receives Patent In U.S. For BeloGal Platform